# Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome

> **NCT01329770** · PHASE2 · COMPLETED · sponsor: **Yolanda de Diego Otero** · enrollment: 30 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01329770
- **Lead sponsor:** Yolanda de Diego Otero
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329770, "Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01329770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*